(2015) 6:4190–201. doi:10.18632/oncotarget.2775 22. HamanakaY,SuehiroY,FukuiM,ShikichiK,ImaiK,HinodaY.Ci rculating anti-MUC1 IgG antibodies as a favorable prognostic factor for panc reatic cancer.IntJCancer. (2003)103:97–100.doi:10.1002/ijc.10801 23. Winter JM, Tang LH, Klimstra DS, Brennan MF, Brody JR, Rocha FG, et al. A novel survival-based tissue microarray of pancreatic cancer validatesMUC1andmesothelinasbiomarkers. PLoSONE.